Skip to main content
SpringerLink
Log in

Ophthalmological Emergencies in Rheumatic and Autoimmune Diseases

  • Chapter
  • First Online:
Autoimmune Diseases

  • 1382 Accesses

Abstract

Sight-threatening autoimmune conditions affect different parts of the visual pathway. This chapter considers ophthalmic emergencies classified anatomically with a discussion of the underlying autoimmune diseases and treatment options. Ophthalmic complications of immunomodulatory treatments are discussed. Finally, the impact of newer immunomodulatory treatments is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Albini TA, Rao NA, Smith RE. The diagnosis and management of anterior scleritis. Int Ophthalmol Clin. 2005;45(2):191-204.

    Article  PubMed  Google Scholar 

  2. Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835-854.

    Article  PubMed  Google Scholar 

  3. Pakrou N, Selva D, Leibovitch I. Wegener’s granulomatosis: ophthalmic manifestations and management (Review). Semin Arthritis Rheum. 2006;35(5):284-292.

    Article  PubMed  Google Scholar 

  4. Malik R, Culinane AB, Tole DM, Cook SD. Rheumatoid keratolysis: a series of 40 eyes. Eur J Ophthalmol. 2006;16(6):791-797.

    PubMed  CAS  Google Scholar 

  5. Liu DT, Chan AY. Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not? Rheumatology. 2006;45(7):920 (author reply 921-922).

    Article  PubMed  CAS  Google Scholar 

  6. Casas VE, Kheirkhah A, Blanco G, Tseng SC. Surgical approach for scleral ischemia and melt. Cornea. 2008;27(2):196-201.

    Article  PubMed  Google Scholar 

  7. Zaidi AA, Ying GS, Daniel E, et al. Hypopyon in patients with uveitis. Ophthalmology. 2010;117(2):366-372.

    Article  PubMed  Google Scholar 

  8. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955-959.

    Article  PubMed  CAS  Google Scholar 

  9. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364-388.

    Article  PubMed  Google Scholar 

  10. Chang JH, Raju R, Henderson TR, McCluskey PJ. Incidence and pattern of acute anterior uveitis in Central Australia. Br J Ophthalmol. 2010;94(2):154-156.

    Article  PubMed  CAS  Google Scholar 

  11. Ali A, Samson CM. Seronegative spondyloarthropathies and the eye (Review). Curr Opin Ophthalmol. 2007;18(6):476-480.

    Article  PubMed  Google Scholar 

  12. Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647-655.

    Article  PubMed  Google Scholar 

  13. Benezra D, Cohen E, Behar-Cohen F. Uveitis and juvenile idiopathic arthritis: a cohort study. Clin Ophthalmol. 2007;1(4):513-518.

    PubMed  Google Scholar 

  14. Hayward K, Wallace CA. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res Ther. 2009;11(1):216.

    Article  PubMed  Google Scholar 

  15. Dodds EM, Irarrázaval LA, Scarfone A, Gáspari E. Bilateral posterior scleritis. Ocul Immunol Inflamm. 1997;5(4):267-269.

    Article  PubMed  CAS  Google Scholar 

  16. Pecorella I, La Cava M, Mannino G, Pinca M, Pezzi PP. Diffuse granulomatous necrotizing scleritis. Acta Ophthalmol Scand. 2006;84(2):263-265.

    Article  PubMed  Google Scholar 

  17. Kim RY, Loewenstein JI. Systemic diseases manifesting as exudative retinal detachment. Int Ophthalmol Clin. 1998;38(1):177-195.

    Article  PubMed  CAS  Google Scholar 

  18. Nag TC, Wadhwa S. Vascular changes of the retina and choroid in systemic lupus erythematosus: pathology and pathogenesis. Curr Neurovasc Res. 2006;3(2):159-168.

    Article  PubMed  Google Scholar 

  19. Coroi M, Bontas E, Defranceschi M, Bartos D, Dorobantu M. Ocular manifestations of antiphospholipid (Hughes)’ syndrome – minor features? Oftalmologia. 2007;51(3):16-22.

    PubMed  Google Scholar 

  20. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol. 2004;32(1):87-100.

    Article  PubMed  Google Scholar 

  21. Stanford MR, Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis. Int Ophthalmol Clin. 2000;40(2):69-83.

    Article  PubMed  CAS  Google Scholar 

  22. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology. 2007;46(12):1757-1762.

    Article  PubMed  CAS  Google Scholar 

  23. McLeod D. Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol. 2005;89:229-237.

    Article  PubMed  CAS  Google Scholar 

  24. Cohen S, Gardner F. Bilateral choroidal ischemia in giant cell arteritis. Arch Ophthalmol. 2006;124(6):922.

    Article  PubMed  Google Scholar 

  25. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34-62.

    Article  PubMed  Google Scholar 

  26. Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist. 2008;14(6):341-354.

    Article  PubMed  Google Scholar 

  27. Vischio JA, McCrary CT. Orbital Wegener’s granulomatosis: a case report and review of the literature. Clin Rheumatol. 2008;27(10):1333-1336.

    Article  PubMed  Google Scholar 

  28. Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115(9):1626-1631.

    Article  PubMed  Google Scholar 

  29. Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol. 2007;144(5):769-775.

    Article  PubMed  Google Scholar 

  30. Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37(4):207-222.

    Article  PubMed  Google Scholar 

  31. Costa RM, Dumitrascu OM, Gordon LK. Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep. 2009;9(4):316-323.

    Article  PubMed  Google Scholar 

  32. Swamy BN, McCluskey P, Nemet A, et al. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91(12):1667-1670.

    Article  PubMed  CAS  Google Scholar 

  33. Silman A, Shipley M. Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data. Br J Rheumatol. 1997;36(5):599-601.

    Article  PubMed  CAS  Google Scholar 

  34. Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of hydroxychloroquine. Semin Ophthalmol. 2008;23(3):201-209.

    Article  PubMed  Google Scholar 

  35. Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009;116(4):652-657.

    Article  PubMed  Google Scholar 

  36. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752-759.

    Article  PubMed  CAS  Google Scholar 

  37. Wiegand TW, Young LH. Cytomegalovirus retinitis. Int Ophthalmol Clin. 2006;46(2):91-110.

    Article  PubMed  Google Scholar 

  38. Tabbara KF. Tuberculosis. Curr Opin Ophthalmol. 2007;18(6):493-501 (Review).

    Article  PubMed  Google Scholar 

  39. Cordero-Coma M, Anzaar F, Yilmaz T, Foster CS. Herpetic retinitis. Herpes. 2007;14(1):4-10.

    PubMed  Google Scholar 

  40. Taban M, Dupps WJ, Mandell B, Perez VL. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm. 2006;14(3):145-150.

    Article  PubMed  Google Scholar 

  41. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum. 2007;56(10):3248-3252.

    Article  PubMed  CAS  Google Scholar 

  42. Sieper J, Koenig A, Baumgartner S, et al. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials. Ann Rheum Dis. 2010;69(1):226-229 (Epub).

    Article  PubMed  CAS  Google Scholar 

  43. Kurz PA, Suhler EB, Choi D, Rosenbaum JT. Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol. 2009;93(4):546-548.

    Article  PubMed  CAS  Google Scholar 

  44. Onal S, Kazokoglu H, Koc A, Yavuz S. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener’s granulomatosis. Ocul Immunol Inflamm. 2008;16(5):230-232.

    Article  PubMed  CAS  Google Scholar 

  45. Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007;56(9):3096-3106.

    Article  PubMed  CAS  Google Scholar 

  46. Gueudry J, Wechsler B, Terrada C, et al. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol. 2008;146(6):837-844 (e1).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Ophthalmology, Medical Eye Unit, St. Thomas’ Hospital, 160 Gloucester Place, NW1 6DT, London, UK

    Edward Pringle

Authors
  1. Edward Pringle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miles Stanford
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edward Pringle .

Editor information

Editors and Affiliations

  1. Rayne Institute, Lupus Research Unit, St. Thomas' Hospital, London, SE1 7EH, United Kingdom

    Munther A. Khamashta

  2. Barcelona, Surgey, Hospital Clinic, Calle Villarroel, 170, Barcelona, 08036, Spain

    Manuel Ramos-Casals

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Pringle, E., Stanford, M. (2011). Ophthalmological Emergencies in Rheumatic and Autoimmune Diseases. In: Khamashta, M., Ramos-Casals, M. (eds) Autoimmune Diseases. Springer, London. https://doi.org/10.1007/978-0-85729-358-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-358-9_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-357-2

  • Online ISBN: 978-0-85729-358-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation